CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $39.04, but opened at $41.30. CochLear shares last traded at $41.30, with a volume of 2,299 shares traded.
Wall Street Analyst Weigh In
CHEOY has been the subject of a number of recent research reports. UBS Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. Jefferies Financial Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price objective for the company. in a report on Thursday, July 16th. Finally, Zacks Research raised shares of CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. One equities research analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $117.00.
View Our Latest Report on CochLear
CochLear Stock Up 4.6%
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than CochLear
- Western Digital’s Earnings Will Test Whether Its AI Rally Has More Room
- Is the Market Mispricing ServiceNow’s AI Future?
- Nano Nuclear’s Air Force Contract Puts Its Short-Squeeze Setup in Focus
- Amkor Sells Off After Earnings—Why Weak Guidance Isn’t the Real Story
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
